Caremark Settlement Reinforces PBM Disclosure, Rx Interchange Standards
Executive Summary
Caremark's settlement of a federal investigation into AdvancePCS' business practices reinforces the rules for pharmacy benefit manager conduct that were first delineated in a Medco consent decree in April 2004
You may also be interested in...
Formulary Discounts Shield Manufacturers From Price Controls – PBMs
Manufacturers should offer pharmacy benefit managers substantial formulary discounts to avoid government price controls, Pharmaceutical Care Management Association President Mark Merritt suggested during the association's annual meeting in Palm Springs, Calif. Oct. 24
Formulary Discounts Shield Manufacturers From Price Controls – PBMs
Manufacturers should offer pharmacy benefit managers substantial formulary discounts to avoid government price controls, Pharmaceutical Care Management Association President Mark Merritt suggested during the association's annual meeting in Palm Springs, Calif. Oct. 24
Caremark Corporate Integrity Agreement Creates Two New Compliance Tasks
Caremark is responsible for two new compliance duties outside of its structured compliance program under a recently signed corporate integrity agreement